Rv1985c, a promising novel antigen for diagnosis of tuberculosis infection from BCG-vaccinated controls
<p>Abstract</p> <p>Background</p> <p>Antigens encoded in the region of difference (RD) of <it>Mycobacterium tuberculosis </it>constitute a potential source of specific antigens for immunodiagnosis. In the present study, recombinant protein Rv1985c from RD2 w...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2010-09-01
|
| Series: | BMC Infectious Diseases |
| Online Access: | http://www.biomedcentral.com/1471-2334/10/273 |
| _version_ | 1818148432486858752 |
|---|---|
| author | Wang Feifei Shao Lingyun Wu Jing Su Xiaodi Zhang Ying Wang Sen Chen Jiazhen Zhang Shu Weng Xinhua Wang Honghai Zhang Wenhong |
| author_facet | Wang Feifei Shao Lingyun Wu Jing Su Xiaodi Zhang Ying Wang Sen Chen Jiazhen Zhang Shu Weng Xinhua Wang Honghai Zhang Wenhong |
| author_sort | Wang Feifei |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>Antigens encoded in the region of difference (RD) of <it>Mycobacterium tuberculosis </it>constitute a potential source of specific antigens for immunodiagnosis. In the present study, recombinant protein Rv1985c from RD2 was cloned, expressed, purified, immunologically characterized and investigated for its potentially diagnostic value for tuberculosis (TB) infection among BCG-vaccinated individuals.</p> <p>Methods</p> <p>T-cell response to Rv1985c was evaluated by IFN-γ ELISPOT in 56 TB patients, 20 latent TB infection (LTBI) and 30 BCG-vaccinated controls in comparison with the commercial T-SPOT. <it>TB </it>kit. Humoral response was evaluated by ELISA in 117 TB patients, 45 LTBI and 67 BCG-vaccinated controls, including all those who had T-cell assay, in comparison with a commercial IgG kit.</p> <p>Results</p> <p>Rv1985c was specifically recognized by cellular and humoral responses from both TB and LTBI groups compared with healthy controls. Rv1985c IgG-ELISA achieved 52% and 62% sensitivity respectively, which outperformed the sensitivity of PATHOZYME-MYCO kit (34%) in detecting active TB (P = 0.011), whereas IFN-γ Rv1985c-ELISPOT achieved 71% and 55% sensitivity in detecting active and LTBI, respectively. Addition of Rv1985c increased sensitivities of ESAT-6, CFP-10 and ESAT-6/CFP-10 combination in detecting TB from 82.1% to 89.2% (P = 0.125), 67.9% to 87.5% (P < 0.001) and 85.7% to 92.9% (P = 0.125), respectively.</p> <p>Conclusions</p> <p>In conclusion, Rv1985c is a novel antigen which can be used to immunologically diagnose TB infection along with other immunodominant antigens among BCG-vaccinated population.</p> |
| first_indexed | 2024-12-11T12:51:03Z |
| format | Article |
| id | doaj.art-334c1b18f30644d7b57b64c6c0dd7f5d |
| institution | Directory Open Access Journal |
| issn | 1471-2334 |
| language | English |
| last_indexed | 2024-12-11T12:51:03Z |
| publishDate | 2010-09-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Infectious Diseases |
| spelling | doaj.art-334c1b18f30644d7b57b64c6c0dd7f5d2022-12-22T01:06:41ZengBMCBMC Infectious Diseases1471-23342010-09-0110127310.1186/1471-2334-10-273Rv1985c, a promising novel antigen for diagnosis of tuberculosis infection from BCG-vaccinated controlsWang FeifeiShao LingyunWu JingSu XiaodiZhang YingWang SenChen JiazhenZhang ShuWeng XinhuaWang HonghaiZhang Wenhong<p>Abstract</p> <p>Background</p> <p>Antigens encoded in the region of difference (RD) of <it>Mycobacterium tuberculosis </it>constitute a potential source of specific antigens for immunodiagnosis. In the present study, recombinant protein Rv1985c from RD2 was cloned, expressed, purified, immunologically characterized and investigated for its potentially diagnostic value for tuberculosis (TB) infection among BCG-vaccinated individuals.</p> <p>Methods</p> <p>T-cell response to Rv1985c was evaluated by IFN-γ ELISPOT in 56 TB patients, 20 latent TB infection (LTBI) and 30 BCG-vaccinated controls in comparison with the commercial T-SPOT. <it>TB </it>kit. Humoral response was evaluated by ELISA in 117 TB patients, 45 LTBI and 67 BCG-vaccinated controls, including all those who had T-cell assay, in comparison with a commercial IgG kit.</p> <p>Results</p> <p>Rv1985c was specifically recognized by cellular and humoral responses from both TB and LTBI groups compared with healthy controls. Rv1985c IgG-ELISA achieved 52% and 62% sensitivity respectively, which outperformed the sensitivity of PATHOZYME-MYCO kit (34%) in detecting active TB (P = 0.011), whereas IFN-γ Rv1985c-ELISPOT achieved 71% and 55% sensitivity in detecting active and LTBI, respectively. Addition of Rv1985c increased sensitivities of ESAT-6, CFP-10 and ESAT-6/CFP-10 combination in detecting TB from 82.1% to 89.2% (P = 0.125), 67.9% to 87.5% (P < 0.001) and 85.7% to 92.9% (P = 0.125), respectively.</p> <p>Conclusions</p> <p>In conclusion, Rv1985c is a novel antigen which can be used to immunologically diagnose TB infection along with other immunodominant antigens among BCG-vaccinated population.</p>http://www.biomedcentral.com/1471-2334/10/273 |
| spellingShingle | Wang Feifei Shao Lingyun Wu Jing Su Xiaodi Zhang Ying Wang Sen Chen Jiazhen Zhang Shu Weng Xinhua Wang Honghai Zhang Wenhong Rv1985c, a promising novel antigen for diagnosis of tuberculosis infection from BCG-vaccinated controls BMC Infectious Diseases |
| title | Rv1985c, a promising novel antigen for diagnosis of tuberculosis infection from BCG-vaccinated controls |
| title_full | Rv1985c, a promising novel antigen for diagnosis of tuberculosis infection from BCG-vaccinated controls |
| title_fullStr | Rv1985c, a promising novel antigen for diagnosis of tuberculosis infection from BCG-vaccinated controls |
| title_full_unstemmed | Rv1985c, a promising novel antigen for diagnosis of tuberculosis infection from BCG-vaccinated controls |
| title_short | Rv1985c, a promising novel antigen for diagnosis of tuberculosis infection from BCG-vaccinated controls |
| title_sort | rv1985c a promising novel antigen for diagnosis of tuberculosis infection from bcg vaccinated controls |
| url | http://www.biomedcentral.com/1471-2334/10/273 |
| work_keys_str_mv | AT wangfeifei rv1985capromisingnovelantigenfordiagnosisoftuberculosisinfectionfrombcgvaccinatedcontrols AT shaolingyun rv1985capromisingnovelantigenfordiagnosisoftuberculosisinfectionfrombcgvaccinatedcontrols AT wujing rv1985capromisingnovelantigenfordiagnosisoftuberculosisinfectionfrombcgvaccinatedcontrols AT suxiaodi rv1985capromisingnovelantigenfordiagnosisoftuberculosisinfectionfrombcgvaccinatedcontrols AT zhangying rv1985capromisingnovelantigenfordiagnosisoftuberculosisinfectionfrombcgvaccinatedcontrols AT wangsen rv1985capromisingnovelantigenfordiagnosisoftuberculosisinfectionfrombcgvaccinatedcontrols AT chenjiazhen rv1985capromisingnovelantigenfordiagnosisoftuberculosisinfectionfrombcgvaccinatedcontrols AT zhangshu rv1985capromisingnovelantigenfordiagnosisoftuberculosisinfectionfrombcgvaccinatedcontrols AT wengxinhua rv1985capromisingnovelantigenfordiagnosisoftuberculosisinfectionfrombcgvaccinatedcontrols AT wanghonghai rv1985capromisingnovelantigenfordiagnosisoftuberculosisinfectionfrombcgvaccinatedcontrols AT zhangwenhong rv1985capromisingnovelantigenfordiagnosisoftuberculosisinfectionfrombcgvaccinatedcontrols |